Rossari Biotech Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company intimated its scheduled participation in investor and analyst meetings/conferences/events. The specific event detailed is:
- Day and Date: Friday, June 12, 2026
- Time: 12:00 PM (IST)
- Event Name: Group Meeting with Kotak PCG Clients
- Meeting Type: One-on-One & Group
- Location: Virtual Conference
The disclosure states that the discussions and presentation at this meeting will be based on financial and other information that is already available to the public. Specifically, it will cover content from the 'Earnings Presentation' that was previously submitted to the stock exchanges on April 28, 2026, and uploaded to the company's website.
Important Notes from the Disclosure
- The date and time of the meeting are subject to change due to exigencies on the part of either the Investors or the Company.
- The company explicitly states that no Unpublished Price Sensitive Information (UPSI) will be shared during the mentioned meeting(s).
The letter was signed by Parul Gupta, Company Secretary & Head - Legal (Membership No.: A38895), requesting the exchanges to take the information on record and disseminate it to all concerned.